End user monitoring - Top priority, but metrics unclear…

Let me describe a recurring situation in almost every organization. When companies deploy critical business applications requiring 99.9% uptime, it’s because users expect this level of delivery. But this is not the reality. The system is up and running and it is close to 99.9% uptime, but the end users are still complaining that the

Read More…

Product Patent Regime in India – the journey from imitation to innovation

When the earth completes a revolution around the sun, it reaches the same place from where it started – but is it exactly the same? Not only has time progressed, it is the beginning of yet another year with countless possibilities and new endeavors. I can say that the Indian pharmaceutical industry has also completed

Read More…

Catching the pulse of the Indian pharma market!!

With global pharmaceutical markets registering sluggish growth (around 4-6%), multinational companies have shifted their attention towards emerging markets like India which grew at the double digit rate of around 13-15% in 2010. Economic growth, increasing healthcare expenditure and the improved Intellectual Property framework has made India an attractive destination. It is currently the third largest market

Read More…

Subscribe 

Archives

  • 2012 (11)
  • +2011 (33)
  • +2010 (32)
  • +2009 (10)